Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in tuberculosis wards

Journal of Infection and Chemotherapy

Volumn 12, Issue 1, 2006, Pages 47-50

  Sekiguchi, Jun Ichiro ^a   Fujino, Tomoko ^a   Araake, Minako ^a   Toyota, Emiko ^a   Kudo, Koichiro ^a   Saruta, Katsutoshi ^a   Yoshikura, Hiroshi ^b   Kuratsuji, Tadatoshi ^a,c   Kirikae, Teruo ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Drug resistance; MRSA; Rifampicin; rpoB; Tuberculosis

Indexed keywords

AMINO ACID; ASPARAGINE; ASPARTIC ACID; DNA; ISOLEUCINE; LEUCINE; NUCLEOTIDE; PHENYLALANINE; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; VALINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DNA SEQUENCE; GENE CLUSTER; GENE MUTATION; HOSPITAL; HUMAN; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATIENT; SCREENING; TUBERCULOSIS; WARD;

EID: 33644582894     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-005-0417-8     Document Type: Article

References (14)

1. ES Darley AP [tmp] MacGowan 2004 Antibiotic treatment of gram-positive bone and joint infections J Antimicrob Chemother 53 928 35
2. FJ Schmitz ME Jones 1997 Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices? Int J Antimicrob Agents 9 1 19
3. W Wehrli 1983 Rifampin: mechanisms of action and resistance Rev Infect Dis 5 S407 11
4. H Aubry-Damon CJ Soussy P Courvalin 1998 Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus Antimicrob Agents Chemother 42 2590 4
5. TA Wichelhaus V Schäfer V Brade B Böddinghaus 1999 Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 43 2813 6
6. TA Wichelhaus V Schäfer V Brade B Böddinghaus 2001 Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus J Antimicrob Chemother 47 153 6
7. TA Wichelhaus B Boddinghaus S Besier V Schafer V Brade A Ludwig 2002 Biological cost of rifampin resistance from the perspective of Staphylococcus aureus Antimicrob Agents Chemother 46 3381 5
8. T Fujino J Sekiguchi A Kawana H Konosaki H Nishimura K Saruta 2004 Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a Tokyo hospital in 2003 Jpn J Infect Dis 57 83 5
9. T Fujino J Sekiguchi A Kawana H Konosaki H Nishimura K Saruta 2002 Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a Tokyo hospital in 2002 Jpn J Infect Dis 55 210 3
10. T Fujino N Mori A Kawana Y Naiki H Kawahata T Kuratsuji K Kudo 2001 Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a Tokyo hospital in 2001 Jpn J Infect Dis 54 240 2
11. T Fujino N Mori A Kawana H Kawabata T Kuratsuji K Kudo 2001 Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a Tokyo hospital in 2000 Jpn J Infect Dis 54 91 3
12. N Mori H Kawata T Hama T Fujino H Kawahata A Kawana 2001 An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) in a tuberculosis ward Jpn J Infect Dis 54 157 9
13. M Hosoda J Toyama K Hasada T Fujino R Ohtsuki T Kirikae 2002 A clonal expansion of methicillin-resistant Staphylococcus aureus (MRSA) in a tuberculosis ward Jpn J Infect Dis 55 19 21
14. National Committee for Clinical Laboratory Standards 2003 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6th ed. M7-A5: 2003 NCCLS Wayne, PA